Sunday, March 9, 2025
spot_img

SalMar – Settlement of acquisition of shares in SalMar Aker Ocean AS – issue of new shares

Frøya, 6 March 2025:

Reference is made to the announcement by SalMar ASA (the “Company”) on 6 March 2025 with information regarding the acquisition of Aker Capital AS’s 15 percent ownership stake in SalMar Aker Ocean AS (the “Transaction”).

Settlement of the Transaction will be made partly in cash and partly by the issuance of 1 million new shares by the Company at a subscription price of NOK 574 per share (the “Consideration Shares”).

The board of directors has today resolved to issue the Consideration Shares as partial settlement for the Transaction, pursuant to an authorisation registered in the Norwegian Register of Business Enterprises on 12 June 2024.

Following the issuance of the Consideration Shares, the Company’s share capital will be NOK 33,438,893, consisting of 133,755,572 shares, each share with a par value of NOK 0.25.

The share capital increase will be registered in the Norwegian Register of Business Enterprises.

For further information, please contact:

Ulrik Steinvik, CFO

Tel: +47 900 84 538
Email: [email protected]

Håkon Husby, Head of Investor Relations
Tel: +47 936 30 449
Email: [email protected]

About SalMar

SalMar is one of the world’s largest and most efficient producers of salmon. The Group has farming operations in Central Norway, Northern Norway and Iceland, as well as substantial harvesting and secondary processing operations. In addition, the company is operating within offshore aquaculture through the company SalMar Aker Ocean and SalMar owns 50% of the shares in Scottish Sea Farms Ltd.

See www.salmar.no for more information about the company.

This information is subject to the disclosure requirements stipulated in section 5-12 of the Norwegian Securities Trading Act.

Powered by SlickText.com

Hot this week

Dupixent® (dupilumab) Late-Breaking Positive Pivotal Data in Bullous Pemphigoid Presented at AAD

Five times more adults on Dupixent achieved sustained disease...

Press Release: Dupixent late-breaking positive pivotal data in bullous pemphigoid presented at AAD

Dupixent late-breaking positive pivotal data in bullous pemphigoid presented...

Kaldalón hf.: Annual General Meeting 3 April 2025

The Board of Directors of Kaldalón hf. hereby announces...

Changes in the Supervisory Board and Management Board of subsidiary

The membership of the Supervisory Board of Aktsiaselts Infortar...

Topics

Press Release: Dupixent late-breaking positive pivotal data in bullous pemphigoid presented at AAD

Dupixent late-breaking positive pivotal data in bullous pemphigoid presented...

Kaldalón hf.: Annual General Meeting 3 April 2025

The Board of Directors of Kaldalón hf. hereby announces...

Changes in the Supervisory Board and Management Board of subsidiary

The membership of the Supervisory Board of Aktsiaselts Infortar...

Holding(s) in Company

Standard Form TR-1 Standard form for notification of...

Rail Vision Receives Nasdaq Notification Regarding Minimum Bid Requirements

Ra’anana, Israel, March 07, 2025 (GLOBE NEWSWIRE)...
spot_img

Related Articles

Popular Categories

spot_img